Product testing provider Eurofins Scientific (Euronext Paris:ERF) confirmed on Monday that it has completed its acquisition of Infinity Laboratories Inc, expanding its biopharma product testing presence in the United States.

Infinity operates eight labs nationwide, offering microbiology, chemistry, sterilisation and packaging testing services to pharma, biotech and medical device companies.

This acquisition broadens Eurofins' microbiology footprint and complements its existing packaging testing services. It strengthens the company's national and global biopharma testing network, providing clients with a wider range of services and expertise.

Infinity benefits from Eurofins' extensive lab network, analytical capabilities and IT systems.